Logo

BioFocus to Offer ChanTest Cell Line Library, Services

Feb 06, 2013 | staff reporter

NEW YORK (GenomeWeb News) – BioFocus today said that it has signed an agreement to offer ChanTest's cell line library and Channel Panel profiling services.

Saffron Walden, UK-based BioFocus said that the alliance will expand its offerings in the fields of ion channel, GPCR, and transporter targets for drug discovery. ChanTest's cell line library contains more than 200 products, BioFocus noted.

Chris Mathes, chief commercial officer of Cleveland-based ChanTest, said that the collaboration "fits well with ChanTest's integrated CRO strategy."

Further terms of the agreement were not disclosed.

Filed under

Cell Biology Research
Drug Discovery & Development
Business News
Business, Policy & Funding
drug screening
cell lines
ChanTest
BioFocus
marketing agreement
cell-based assays
GPCR screening
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.